Oncotelic Therapeutics, Inc.

OTLC·OTC·$0.06Share Price as of 11/2·$27MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/14/26 10-KFY 202504/15/26 10-QQ3 ended 09/30/2511/17/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report10/26/26 8-KCurrent report10/13/26 8-KCurrent report08/04/26 8-KCurrent report07/14/26 8-KCurrent report07/14/26

Prospectuses and Registrations

424B3Prospectus12/23/25 S-1/ARegistration statement (amended)12/22/25 S-1Registration statement (IPO)11/21/25 424B3Prospectus04/29/25 POS AMPost-effective amendment04/15/25

Proxies

DEF 14ADefinitive proxy06/25/20 PRER14APreliminary proxy (revised)05/20/20 PRER14APreliminary proxy (revised)04/17/20 PRE 14APreliminary proxy04/13/20 PRER14APreliminary proxy (revised)11/18/19

Ownership

Form 4Insider transaction10/30/26 Form 4Insider transaction07/23/26 Form 4Insider transaction07/21/26 Form 4Insider transaction07/14/26 Form 4Insider transaction07/14/26

Other

DD07/22/26 NT 10-KLate filing notification (10-K)03/31/26 EFFECTRequest for effectiveness12/23/25 CORRESPCorrespondence with the SEC12/22/25 DD12/11/25